newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement

Provides exclusive world-wide patent rights to the use of rNAPc2 as a potential treatment for COVID-19 and other indications WESTMINSTER, Colo., July 07, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ:ABIO) today announced it has entered in